Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Hydroxychloroquine × Clear all

NCT01550367 2020-01-02

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

Phase 1/2 Completed

30 enrolled 20 charts

Carcinoma, Renal Cell